{"symbol":"SZ002223","secucode":"002223.SZ","items":[{"title":"鱼跃医疗回购637万股 金额1.62亿元","summary":"8月3日，鱼跃医疗（002223）发布公告，截至2026年7月31日，公司已回购637万股，占总股本的0.6357%，回购总金额为1.62亿元，回购价格区间为23.91元/股至26.14元/股。2026年一季度，鱼跃医疗实现收入23.70亿元，归母净利润4.28亿元。","source":null,"url":"http://finance.eastmoney.com/news/1354,202608033829971577.html","info_code":"NW202608033829971577","show_time_timestamp":1785759480000,"show_time":"2026-08-03 20:18:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202608033829971577.html","url":"http://finance.eastmoney.com/news/1354,202608033829971577.html","code":"202608033829971577","infoCode":"NW202608033829971577","recordId":null,"source":null,"title":"鱼跃医疗回购637万股 金额1.62亿元","updateTime":0,"showDateTime":1785759480000,"publishDate":0,"sRatingName":null,"summary":"8月3日，鱼跃医疗（002223）发布公告，截至2026年7月31日，公司已回购637万股，占总股本的0.6357%，回购总金额为1.62亿元，回购价格区间为23.91元/股至26.14元/股。2026年一季度，鱼跃医疗实现收入23.70亿元，归母净利润4.28亿元。"}},{"title":"鱼跃医疗：公司目前有脱毛仪、光能大排灯等产品在售","summary":"证券日报网讯8月3日，鱼跃医疗在互动平台回答投资者提问时表示，公司目前有脱毛仪、光能大排灯等产品在售，占公司营业收入比重较小。","source":null,"url":"http://finance.eastmoney.com/news/1354,202608033829806034.html","info_code":"NW202608033829806034","show_time_timestamp":1785745140000,"show_time":"2026-08-03 16:19:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202608033829806034.html","url":"http://finance.eastmoney.com/news/1354,202608033829806034.html","code":"202608033829806034","infoCode":"NW202608033829806034","recordId":null,"source":null,"title":"鱼跃医疗：公司目前有脱毛仪、光能大排灯等产品在售","updateTime":0,"showDateTime":1785745140000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯8月3日，鱼跃医疗在互动平台回答投资者提问时表示，公司目前有脱毛仪、光能大排灯等产品在售，占公司营业收入比重较小。"}},{"title":"宁德时代拟200亿至400亿元回购股份；德明利董事长承诺12个月内不减持丨公告精选","summary":"今日焦点宁德时代拟以200亿至400亿元回购股份并用于注销宁德时代公告称，公司拟使用自有或自筹资金以集中竞价交易方式回购公司A股股份，回购资金总额不低于200亿元且不超过400亿元，回购价格上限为573元/股。回购的股份将用于注销并减少公司注册资本，回购期限自股东会审议通过之日起12个月内。","source":null,"url":"http://finance.eastmoney.com/news/1354,202607243820799268.html","info_code":"NW202607243820799268","show_time_timestamp":1784902860000,"show_time":"2026-07-24 22:21:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607243820799268.html","url":"http://finance.eastmoney.com/news/1354,202607243820799268.html","code":"202607243820799268","infoCode":"NW202607243820799268","recordId":null,"source":null,"title":"宁德时代拟200亿至400亿元回购股份；德明利董事长承诺12个月内不减持丨公告精选","updateTime":0,"showDateTime":1784902860000,"publishDate":0,"sRatingName":null,"summary":"今日焦点宁德时代拟以200亿至400亿元回购股份并用于注销宁德时代公告称，公司拟使用自有或自筹资金以集中竞价交易方式回购公司A股股份，回购资金总额不低于200亿元且不超过400亿元，回购价格上限为573元/股。回购的股份将用于注销并减少公司注册资本，回购期限自股东会审议通过之日起12个月内。"}},{"title":"鱼跃医疗穿戴化战略取得阶段性成果 腕部动态血压记录仪获证","summary":"上证报中国证券网讯7月24日晚间，鱼跃医疗披露公告称，公司收到江苏省药品监督管理局颁发的关于腕部动态血压记录仪的《医疗器械注册证》。据介绍，该产品的血压监测功能已取得《医疗器械注册证》，支持单次血压测量、24小时动态血压测量及夜间血压监测，可记录用户的血压数据并呈现变化趋势，并具备心率、血氧、压力、睡眠等健康参数监测功能，可用于辅助用户开展日常健康管理。","source":null,"url":"http://finance.eastmoney.com/news/1354,202607243820682468.html","info_code":"NW202607243820682468","show_time_timestamp":1784896080000,"show_time":"2026-07-24 20:28:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607243820682468.html","url":"http://finance.eastmoney.com/news/1354,202607243820682468.html","code":"202607243820682468","infoCode":"NW202607243820682468","recordId":null,"source":null,"title":"鱼跃医疗穿戴化战略取得阶段性成果 腕部动态血压记录仪获证","updateTime":0,"showDateTime":1784896080000,"publishDate":0,"sRatingName":null,"summary":"上证报中国证券网讯7月24日晚间，鱼跃医疗披露公告称，公司收到江苏省药品监督管理局颁发的关于腕部动态血压记录仪的《医疗器械注册证》。据介绍，该产品的血压监测功能已取得《医疗器械注册证》，支持单次血压测量、24小时动态血压测量及夜间血压监测，可记录用户的血压数据并呈现变化趋势，并具备心率、血氧、压力、睡眠等健康参数监测功能，可用于辅助用户开展日常健康管理。"}},{"title":"鱼跃医疗(002223.SZ)：腕部动态血压记录仪获Ⅱ类医疗器械注册证，支持24小时动态血压及健康参数监测","summary":"2026年7月24日，江苏鱼跃医疗设备股份有限公司（002223.SZ）发布公告称，公司近日收到江苏省药品监督管理局颁发的腕部动态血压记录仪《医疗器械注册证》，注册分类为Ⅱ类，注册证编号苏械注准20262071109，有效期自2026年7月24日至2031年7月23日，共12种型号（WBA10-WBA61）。","source":null,"url":"http://finance.eastmoney.com/news/1354,202607243820566563.html","info_code":"NW202607243820566563","show_time_timestamp":1784886317000,"show_time":"2026-07-24 17:45:17","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607243820566563.html","url":"http://finance.eastmoney.com/news/1354,202607243820566563.html","code":"202607243820566563","infoCode":"NW202607243820566563","recordId":null,"source":null,"title":"鱼跃医疗(002223.SZ)：腕部动态血压记录仪获Ⅱ类医疗器械注册证，支持24小时动态血压及健康参数监测","updateTime":0,"showDateTime":1784886317000,"publishDate":0,"sRatingName":null,"summary":"2026年7月24日，江苏鱼跃医疗设备股份有限公司（002223.SZ）发布公告称，公司近日收到江苏省药品监督管理局颁发的腕部动态血压记录仪《医疗器械注册证》，注册分类为Ⅱ类，注册证编号苏械注准20262071109，有效期自2026年7月24日至2031年7月23日，共12种型号（WBA10-WBA61）。"}}]}